Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 6/2011

01.07.2011 | Original Paper

The assessment of Shin’s method for the prediction of creatinine kinase-MB elevation after percutaneous coronary intervention: an intravascular ultrasound study

verfasst von: Eun-Seok Shin, Hector M. Garcia-Garcia, Scot Garg, Jongha Park, Shin-Jae Kim, Patrick W. Serruys

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Cardiac enzyme release is common after percutaneous coronary intervention (PCI). At present there is no established relationship between the quantity of necrotic core and dense calcium, as assessed by Shin’s method using intravascular ultrasound virtual histology (VH-IVUS), and post-PCI creatinine kinase-MB (CK-MB) elevation. A total of 112 consecutive patients with unstable angina and a normal pre-PCI CK-MB level were imaged using VH-IVUS. Patients were divided into 2 groups according to the presence (CK-MB group,= 22) or absence (non CK-MB group,= 90) of a post-PCI CK-MB elevation >1.0 the upper limit of normal (3.6 ng/ml). Using Shin’s method contours were drawn around the IVUS catheter (instead of the lumen), and the vessel. Mean area and volume of necrotic core and dense calcium were significantly greater in CK-MB group than in non CK-MB group (1.7 ± 0.9 mm2 vs. 0.9 ± 0.6 mm2, P < 0.001; 17.2 ± 8.8 mm3 vs. 8.8 ± 5.8 mm3, P < 0.001, and 0.9 ± 0.6 mm2 vs. 0.4 ± 0.4 mm2, P = 0.001; 9.1 ± 5.8 mm3 vs. 3.9 ± 3.7 mm3, P < 0.001, respectively). Percent necrotic core and dense calcium areas calculated by external elastic membrane (EEM) area were significantly greater in CK-MB group than in non CK-MB group (11.9 ± 5.1 vs. 6.6 ± 4.0%, P < 0.001 and 6.5 ± 4.0 vs. 3.0 ± 2.9%, P < 0.001, respectively). In the multivariate analysis, dense calcium volume and percent necrotic core to EEM at the most diseased segment were the only independent predictors of post-PCI CK-MB elevation (odds ratio: 1.22; 95% confidence interval: 1.09–1.37, P < 0.001 and odds ratio: 1.26; 95% confidence interval: 1.12–1.43, P < 0.001). Lesions with a greater amount of dense calcium volume and percent necrotic core to EEM, which can be easily identified and quantified on VH-IVUS analyzed using Shin’s method, are responsible for post-PCI CK-MB elevation. With a rapid analyzing time, Shin’s method may increase the identification of high risk lesions likely to induce a post-procedural myocardial injury in the catheterization laboratory facilitating on-line clinical decision making.
Literatur
1.
Zurück zum Zitat Topol EJ, Ferguson JJ, Weisman HF et al (1997) Long-term protection from myocardial ischemic events in a randomized trial of brief integrin {beta}3 blockade with percutaneous coronary intervention. JAMA 278:479–484PubMedCrossRef Topol EJ, Ferguson JJ, Weisman HF et al (1997) Long-term protection from myocardial ischemic events in a randomized trial of brief integrin {beta}3 blockade with percutaneous coronary intervention. JAMA 278:479–484PubMedCrossRef
2.
Zurück zum Zitat Tardiff BE, Califf RM, Tcheng JE et al (1999) Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. J Am Coll Cardiol 33:88–96PubMedCrossRef Tardiff BE, Califf RM, Tcheng JE et al (1999) Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. J Am Coll Cardiol 33:88–96PubMedCrossRef
3.
Zurück zum Zitat Califf RM, Abdelmeguid AE, Kuntz RE et al (1998) Myonecrosis after revascularization procedures. J Am Coll Cardiol 31:241–251PubMedCrossRef Califf RM, Abdelmeguid AE, Kuntz RE et al (1998) Myonecrosis after revascularization procedures. J Am Coll Cardiol 31:241–251PubMedCrossRef
4.
Zurück zum Zitat Ricciardi MJ, Davidson CJ, Gubernikoff G et al (2003) Troponin I elevation and cardiac events after percutaneous coronary intervention. Am Heart J 145:522–528PubMedCrossRef Ricciardi MJ, Davidson CJ, Gubernikoff G et al (2003) Troponin I elevation and cardiac events after percutaneous coronary intervention. Am Heart J 145:522–528PubMedCrossRef
5.
Zurück zum Zitat Mehran R, Dangas G, Mintz GS et al (2000) Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravascular ultrasound study of 2256 patients. Circulation 101:604–610PubMed Mehran R, Dangas G, Mintz GS et al (2000) Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravascular ultrasound study of 2256 patients. Circulation 101:604–610PubMed
6.
Zurück zum Zitat Hong YJ, Mintz GS, Kim SW et al (2009) Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis. JACC Cardiovasc Imaging 2:458–468PubMedCrossRef Hong YJ, Mintz GS, Kim SW et al (2009) Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis. JACC Cardiovasc Imaging 2:458–468PubMedCrossRef
7.
Zurück zum Zitat Nasu K, Tsuchikane E, Katoh O et al (2006) Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol 47:2405–2412PubMedCrossRef Nasu K, Tsuchikane E, Katoh O et al (2006) Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol 47:2405–2412PubMedCrossRef
8.
Zurück zum Zitat Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG (2002) Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 106:2200–2206PubMedCrossRef Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG (2002) Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 106:2200–2206PubMedCrossRef
9.
Zurück zum Zitat Shin ES, Garcia-Garcia HM, Serruys PW (2010) A new method to measure necrotic core and calcium content in coronary plaques using intravascular ultrasound radiofrequency-based analysis. Int J Cardiovasc Imaging 26:387–396PubMedCrossRef Shin ES, Garcia-Garcia HM, Serruys PW (2010) A new method to measure necrotic core and calcium content in coronary plaques using intravascular ultrasound radiofrequency-based analysis. Int J Cardiovasc Imaging 26:387–396PubMedCrossRef
10.
Zurück zum Zitat The Thrombolysis in Myocardial Infarction (TIMI) trial (1985) Phase I findings. TIMI study group. N Engl J Med 312:932–936 The Thrombolysis in Myocardial Infarction (TIMI) trial (1985) Phase I findings. TIMI study group. N Engl J Med 312:932–936
11.
Zurück zum Zitat Gibson CM, Cannon CP, Daley WL et al (1996) TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93:879–888PubMed Gibson CM, Cannon CP, Daley WL et al (1996) TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93:879–888PubMed
12.
Zurück zum Zitat Porto I, Selvanayagam JB, Van Gaal WJ et al (2006) Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation 114:662–669PubMedCrossRef Porto I, Selvanayagam JB, Van Gaal WJ et al (2006) Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation 114:662–669PubMedCrossRef
13.
Zurück zum Zitat Hong MK, Mehran R, Dangas G et al (1999) Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 100:2400–2405PubMed Hong MK, Mehran R, Dangas G et al (1999) Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 100:2400–2405PubMed
14.
Zurück zum Zitat Akkerhuis KM, Alexander JH, Tardiff BE et al (2002) Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? Circulation 105:554–556PubMedCrossRef Akkerhuis KM, Alexander JH, Tardiff BE et al (2002) Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? Circulation 105:554–556PubMedCrossRef
15.
Zurück zum Zitat Kong TQ Jr, Davidson CJ, Meyers SN, Tauke JT, Parker MA, Bonow RO (1997) Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA 277:461–466PubMedCrossRef Kong TQ Jr, Davidson CJ, Meyers SN, Tauke JT, Parker MA, Bonow RO (1997) Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA 277:461–466PubMedCrossRef
16.
Zurück zum Zitat Locca D, Bucciarelli-Ducci C, Ferrante G et al (2010) New universal definition of myocardial infarction applicable after complex percutaneous coronary interventions? JACC Cardiovasc Interv 3:950–958PubMedCrossRef Locca D, Bucciarelli-Ducci C, Ferrante G et al (2010) New universal definition of myocardial infarction applicable after complex percutaneous coronary interventions? JACC Cardiovasc Interv 3:950–958PubMedCrossRef
17.
Zurück zum Zitat Ricciardi MJ, Wu E, Davidson CJ et al (2001) Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 103:2780–2783PubMedCrossRef Ricciardi MJ, Wu E, Davidson CJ et al (2001) Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 103:2780–2783PubMedCrossRef
18.
Zurück zum Zitat Brener SJ, Lytle BW, Schneider JP, Ellis SG, Topol EJ (2002) Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. J Am Coll Cardiol 40:1961–1967PubMedCrossRef Brener SJ, Lytle BW, Schneider JP, Ellis SG, Topol EJ (2002) Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. J Am Coll Cardiol 40:1961–1967PubMedCrossRef
19.
Zurück zum Zitat Bhatt DL, Topol EJ (2005) Periprocedural cardiac enzyme elevation predicts adverse outcomes. Circulation 112:906–922PubMedCrossRef Bhatt DL, Topol EJ (2005) Periprocedural cardiac enzyme elevation predicts adverse outcomes. Circulation 112:906–922PubMedCrossRef
20.
Zurück zum Zitat Kawaguchi R, Oshima S, Jingu M et al (2007) Usefulness of virtual histology intravascular ultrasound to predict distal embolization for ST-segment elevation myocardial infarction. J Am Coll Cardiol 50:1641–1646PubMedCrossRef Kawaguchi R, Oshima S, Jingu M et al (2007) Usefulness of virtual histology intravascular ultrasound to predict distal embolization for ST-segment elevation myocardial infarction. J Am Coll Cardiol 50:1641–1646PubMedCrossRef
21.
Zurück zum Zitat Kawamoto T, Okura H, Koyama Y et al (2007) The relationship between coronary plaque characteristics and small embolic particles during coronary stent implantation. J Am Coll Cardiol 50:1635–1640PubMedCrossRef Kawamoto T, Okura H, Koyama Y et al (2007) The relationship between coronary plaque characteristics and small embolic particles during coronary stent implantation. J Am Coll Cardiol 50:1635–1640PubMedCrossRef
22.
Zurück zum Zitat (2000) Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial. Lancet 356:2037–2044 (2000) Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial. Lancet 356:2037–2044
23.
Zurück zum Zitat Bonz AW, Lengenfelder B, Strotmann J et al (2002) Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial). J Am Coll Cardiol 40:662–668PubMedCrossRef Bonz AW, Lengenfelder B, Strotmann J et al (2002) Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial). J Am Coll Cardiol 40:662–668PubMedCrossRef
24.
Zurück zum Zitat Valgimigli M, Percoco G, Barbieri D et al (2004) The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: The advance trial. J Am Coll Cardiol 44:14–19PubMedCrossRef Valgimigli M, Percoco G, Barbieri D et al (2004) The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: The advance trial. J Am Coll Cardiol 44:14–19PubMedCrossRef
25.
Zurück zum Zitat Briguori C, Visconti G, Focaccio A et al (2009) Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction. J Am Coll Cardiol 54:2157–2163PubMedCrossRef Briguori C, Visconti G, Focaccio A et al (2009) Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction. J Am Coll Cardiol 54:2157–2163PubMedCrossRef
26.
Zurück zum Zitat Angelini A, Rubartelli P, Mistrorigo F et al (2004) Distal protection with a filter device during coronary stenting in patients with stable and unstable angina. Circulation 110:515–521PubMedCrossRef Angelini A, Rubartelli P, Mistrorigo F et al (2004) Distal protection with a filter device during coronary stenting in patients with stable and unstable angina. Circulation 110:515–521PubMedCrossRef
Metadaten
Titel
The assessment of Shin’s method for the prediction of creatinine kinase-MB elevation after percutaneous coronary intervention: an intravascular ultrasound study
verfasst von
Eun-Seok Shin
Hector M. Garcia-Garcia
Scot Garg
Jongha Park
Shin-Jae Kim
Patrick W. Serruys
Publikationsdatum
01.07.2011
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 6/2011
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-010-9734-9

Weitere Artikel der Ausgabe 6/2011

The International Journal of Cardiovascular Imaging 6/2011 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.